Food And Drug Administration-Basal Cell Carcinoma-Skin Cancer

FDA approves first drug for common skin cancer

The Food and Drug Administration has for the first time approved a drug to treat advanced cases of the most common Skin Cancer, basal cell carcinoma, the agency announced. read more..

source:http://on.msnbc.com/xBEhEQ

Basal Cell Carcinoma-Skin Cancer

US approves new drug for common skin cancer

Erivedge (vismodegib) is made by Genentech, a US subsidiary of the Swiss drug giant Roche

US authorities on Monday approved a new drug to treat the most common form of skin cancer, basal cell carcinoma, which is rarely lethal but can spread if left untreated. read more..

source:http://yhoo.it/wUFGby